Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Andrew Bushell

B.Sc., D. Phil

Senior Researcher

  • Senior Post-Doctoral fellow and University Research Lecturer

Summary of Research

Transplantation is rightly described as a miracle of modern medicine but the survival of transplanted organs and tissues depends on the patient receiving life-long immunosuppressive therapy to prevent rejection.  Although very effective in the short-term, immunosuppressive drugs increase the risk of serious complications including opportunistic infections, vascular disease, cancer and diabetes.  In the last 10-15 years it has become apparent that the mammalian immune system has evolved multiple mechanisms for preventing harmful autoimmune responses.  One of the most powerful components of this control system is provided by populations known as regulatory T cells (Treg).  We and others have shown that Treg can prevent transplant rejection independently of long-term therapeutic intervention.  Thus, the aims of our work are three-fold:-

  1. Understand how Treg develop and how they control immune responses.
  2. Develop and optimise protocols to generate/expand Treg and apply them to models relevant to clinical transplantation.
  3. Develop human Treg protocols suitable for use in kidney transplant patients

The hope is that by engaging natural, physiological control mechanisms, it may be possible to achieve long-term organ transplant survival and function in patients with only minimal levels of drug-based immunosuppression


False False

Subject Areas


Direct Entry Research Degrees